Vinorelbine tartrate and Neoplasm progression - a phase IV clinical study of FDA data

Summary:

Neoplasm progression is found among people who take Vinorelbine tartrate, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Vinorelbine tartrate and have Neoplasm progression. It is created by eHealthMe based on reports of 2,220 people who have side effects when taking Vinorelbine tartrate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 17, 2022

2,220 people reported to have side effects when taking Vinorelbine tartrate.
Among them, 117 people (5.27%) have Neoplasm progression.


What is Vinorelbine tartrate?

Vinorelbine tartrate has active ingredients of vinorelbine tartrate. eHealthMe is studying from 2,227 Vinorelbine tartrate users for its effectiveness, alternative drugs and more.

What is Neoplasm progression?

Neoplasm progression (growth of tumour) is found to be associated with 1,207 drugs and 787 conditions by eHealthMe.

Number of Vinorelbine tartrate and Neoplasm progression reports submitted per year:

Could Vinorelbine tartrate cause Neoplasm progression?

Time on Vinorelbine tartrate when people have Neoplasm progression *:

Click here to view

Gender of people who have Neoplasm progression when taking Vinorelbine tartrate*:

Click here to view

Age of people who have Neoplasm progression when taking Vinorelbine tartrate *:

Click here to view

Common drugs people take besides Vinorelbine tartrate *:

Click here to view

Common side effects people have besides Neoplasm progression *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Vinorelbine tartrate and have Neoplasm progression?

Check whether Neoplasm progression is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Vinorelbine tartrate:

Neoplasm progression treatments and more:

COVID vaccines that are related to Neoplasm progression:

How severe was Neoplasm progression and when was it recovered:

Expand to all the drugs that have ingredients of vinorelbine tartrate:

Common drugs associated with Neoplasm progression:

All the drugs that are associated with Neoplasm progression:

Common conditions associated with Neoplasm progression:

All the conditions that are associated with Neoplasm progression:

How the study uses the data?

The study uses data from the FDA. It is based on vinorelbine tartrate (the active ingredients of Vinorelbine tartrate) and Vinorelbine tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: